万邦医药：公司控制的合伙企业拟认购基金份额

Group 1 - The core point of the article is that Wanbang Medical announced a strategic investment to enhance its competitive edge by participating in a partnership with a venture capital firm, committing 10 million yuan for a 12.99% stake in the fund [1] - Wanbang Medical's revenue composition for the year 2024 is entirely from the CRO industry, indicating a focused business model [1] - As of the report, Wanbang Medical has a market capitalization of 2.7 billion yuan [1] Group 2 - The article also highlights a significant growth in the new energy heavy truck sector, with November sales increasing by 178% year-on-year, indicating strong demand and supply challenges [1]